Literature DB >> 30933257

Mycoplasma Ocular Infection in Subretinal Graft Transplantation of iPS Cells-Derived Retinal Pigment Epithelial Cells.

Kenichi Makabe1,2, Sunao Sugita1, Ayumi Hono1, Hiroyuki Kamao3, Masayo Takahashi1.   

Abstract

Purpose: To report occurrence of acute severe inflammation after surgical implantation of mycoplasma-infected induced pluripotent stem cell-derived RPE (iPS-RPE) cells into the eyes of healthy primates, and determine the immunopathological mechanisms of the inflammation.
Methods: Ophthalmic allogeneic transplantation of iPS-RPE cells was performed in the subretina of major histocompatibility complex (MHC)-matched (two eyes) and MHC-mismatched (one eye) healthy cynomolgus monkeys. The clinical course after transplantation was observed using color fundus photography, fluorescence angiography, and optical coherence tomography. After the animals were killed at 1 month after surgery, eyeballs were removed and pathologically examined. Microorganisms were analyzed by PCR methods and BLAST analysis using preserved graft iPS-RPE cells and the recipients' vitreous humor. Mixed lymphocyte-RPE assay was performed on the mycoplasma-infected and noninfected iPS-RPE cells in vitro.
Results: In tested eyes, abnormal findings were observed in the grafted retina 2 weeks after surgery. Here, we observed retinal vasculitis and hemorrhage, retinal detachment, and infiltration of inflammatory cells into the retina of the eyes. One month after surgery, animals were killed due to the severe immune responses observed. Using PCR methods, sequence analysis detected mycoplasma-DNA (Mycoplasma arginini species) in both the grafted RPE cells and the collected vitreous fluids of the monkeys. Mixed lymphocyte-RPE assay revealed that the infected iPS-RPE cells enhanced the proliferation of inflammatory cells in vitro. Conclusions: Transplantation of graft iPS-RPE cells contaminated with mycoplasma into the subretina caused severe ocular inflammation. Mycoplasma possesses the ability to cause immune responses in the host.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30933257     DOI: 10.1167/iovs.18-26222

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  3 in total

1.  A Strategy for Personalized Treatment of iPS-Retinal Immune Rejections Assessed in Cynomolgus Monkey Models.

Authors:  Shota Fujii; Sunao Sugita; Yoko Futatsugi; Masaaki Ishida; Ayaka Edo; Kenichi Makabe; Hiroyuki Kamao; Yuko Iwasaki; Hirokazu Sakaguchi; Yasuhiko Hirami; Yasuo Kurimoto; Masayo Takahashi
Journal:  Int J Mol Sci       Date:  2020-04-27       Impact factor: 5.923

2.  Distributed automated manufacturing of pluripotent stem cell products.

Authors:  Maryam Shariatzadeh; Amit Chandra; Samantha L Wilson; Mark J McCall; Lise Morizur; Léa Lesueur; Olivier Chose; Michael M Gepp; André Schulz; Julia C Neubauer; Heiko Zimmermann; Elsa Abranches; Jennifer Man; Orla O'Shea; Glyn Stacey; Zoe Hewitt; David J Williams
Journal:  Int J Adv Manuf Technol       Date:  2019-12-04       Impact factor: 3.226

3.  Detection of Mycoplasma Contamination in Transplanted Retinal Cells by Rapid and Sensitive Polymerase Chain Reaction Test.

Authors:  Sunao Sugita; Ayumi Hono; Shoko Fujino; Yoko Futatsugi; Yuta Yunomae; Norio Shimizu; Masayo Takahashi
Journal:  Int J Mol Sci       Date:  2021-11-21       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.